Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 502841 - 502860 out of 504621 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| USA | (J05AE10) darunavir (adm: O) | PREZISTA 800MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
HIV Infections | JanssenProducts,LP |
| USA | (J05AE10) darunavir (adm: O) | PREZISTA 800MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
HIV Infections | JanssenProducts,LP |
| USA | (J05AE30) nirmatrelvir and ritonavir (adm: O, refers to nirmatrelvir) | PAXLOVID 150-100MG DOSE PACK (SEVERE RENAL DO | 11 | Ex-factory price without vat |
$0-0 |
$0-0 |
COVID-19 virus infection | PfizerInc. |
| USA | (J05AE30) nirmatrelvir and ritonavir (adm: O, refers to nirmatrelvir) | PAXLOVID 150-100MG DOSE PACK (SEVERE RENAL DO | 11 | Ex-factory price without vat |
$0-0 |
$0-0 |
COVID-19 virus infection | PfizerInc. |
| USA | (J05AE30) nirmatrelvir and ritonavir (adm: O, refers to nirmatrelvir) | PAXLOVID 150MG/100MG TAB,5-DAY RENAL PACK | 20 | Ex-factory price without vat |
$0-0 |
$0-0 |
COVID-19 virus infection | PfizerInc. |
| USA | (J05AE30) nirmatrelvir and ritonavir (adm: O, refers to nirmatrelvir) | PAXLOVID 150MG/100MG TAB,5-DAY RENAL PACK | 20 | Ex-factory price without vat |
$0-0 |
$0-0 |
COVID-19 virus infection | PfizerInc. |
| USA | (J05AE30) nirmatrelvir and ritonavir (adm: O, refers to nirmatrelvir) | PAXLOVID 300MG/100MG TAB,5-DAILY PACK | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
COVID-19 virus infection | PfizerInc. |
| USA | (J05AE30) nirmatrelvir and ritonavir (adm: O, refers to nirmatrelvir) | PAXLOVID 300MG/100MG TAB,5-DAILY PACK | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
COVID-19 virus infection | PfizerInc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 40MG ORAL POWDER | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 40MG ORAL POWDER | 60 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 150MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 150MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 200MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 200MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 250MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 250MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 300MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF07) tenofovir disoproxil (adm: O) | VIREAD 300MG TAB | 30 | Ex-factory price without vat |
$0-0 |
$0-0 |
Hepatitis B, Chronic;HIV Infections | GileadSciences,Inc. |
| USA | (J05AF09) emtricitabine (adm: O) | EMTRIVA 10MG/ML ORAL SOLN | 170ML | Ex-factory price without vat |
$0-0 |
$0-0 |
HIV Infections | GileadSciences,Inc. |
| USA | (J05AF09) emtricitabine (adm: O) | EMTRIVA 10MG/ML ORAL SOLN | 170ML | Ex-factory price without vat |
$0-0 |
$0-0 |
HIV Infections | GileadSciences,Inc. |
Pages
